These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8856301)

  • 1. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
    Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
    Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: correlation with clinical prognosis.
    Leung TW; Cheung AN; Cheng DK; Wong LC; Ngan HY
    Oncol Rep; 2001; 8(5):1159-64. PubMed ID: 11496335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis.
    Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
    Arch Gynecol Obstet; 2011 Mar; 283(3):611-6. PubMed ID: 20405295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma.
    Tateishi M; Ishida T; Kohdono S; Hamatake M; Fukuyama Y; Sugimachi K
    Surg Oncol; 1994 Apr; 3(2):109-13. PubMed ID: 7952390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of c-erbB-2 and PCNA expression in adenocarcinoma of uterine cervix].
    Huang Y; Cai S; Yu S
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):150-2. PubMed ID: 10743084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
    Sato S; Ito K; Ozawa N; Yajima A; Sasano H
    Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
    Nishio S; Ushijima K; Yamaguchi T; Sasajima Y; Tsuda H; Kasamatsu T; Kage M; Ono M; Kuwano M; Kamura T
    Gynecol Oncol; 2014 Mar; 132(3):703-8. PubMed ID: 24486603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
    Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
    Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression.
    Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
    Gynecol Oncol; 2002 Jun; 85(3):469-75. PubMed ID: 12051876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of erb-B2 immunoreactivity in cervical cancer.
    Califano D; Losito S; Pisano C; Santelli G; Greggi S; Iodice F; DiVagno G; Silvestro G; Tambaro R; Formato R; Iaffaioli VR; Di Maio M; Pignata S
    Front Biosci; 2006 Sep; 11():2071-6. PubMed ID: 16720293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters.
    Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
    Anticancer Res; 2010 Apr; 30(4):1341-5. PubMed ID: 20530450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
    Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
    World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H
    Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.
    Barbu I; Crăiţoiu S; Simionescu CE; Drâgnei AM; Mărgăritescu C
    Rom J Morphol Embryol; 2013; 54(3):519-30. PubMed ID: 24068399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
    Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
    BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
    Costa MJ; Walls J; Trelford JD
    Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.